The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is an aggressive human cancer with increasing incidence worldwide. Multiple efforts have been made to explore pharmaceutical therapies to treat HCC, such as targeted tyrosine kinase inhibitors, immune based therapies and combination of chemotherapy. However, limitations exist in current strategies including chemoresistance for instance. Tumor initiation and progression is driven by reprogramming of metabolism, in particular during HCC development. Recently, metabolic associated fatty liver disease (MAFLD), a reappraisal of new nomenclature for non-alcoholic fatty liver disease (NAFLD), indicates growing appreciation of metabolism in the pathogenesis of liver disease, including HCC, thereby suggesting new strategies by targeting abnormal metabolism for HCC treatment. In this review, we introduce directions by highlighting the metabolic targets in glucose, fatty acid, amino acid and glutamine metabolism, which are suitable for HCC pharmaceutical intervention. We also summarize and discuss current pharmaceutical agents and studies targeting deregulated metabolism during HCC treatment. Furthermore, opportunities and challenges in the discovery and development of HCC therapy targeting metabolism are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-642_1 · Cited by 2,081
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Glucose feeds the TCA cycle via circulating lactate
Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W., Esparza, L. A., Reya, T., Zhan, L., Yanxiang Guo, J., et al. (2017) · Nature · doi:10.1038/nature24057 · Cited by 1,721
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,115
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
Zhu, A. X., Park, J. O., Ryoo, B.-Y., Yen, C.-J., Poon, R., Pastorelli, D., Blanc, J.-F., Chung, H. C., Baron, A. D., Pfiffer, T. E. F., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00050-9 · Cited by 846
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Ray, K. K., Bays, H. E., Catapano, A. L., Lalwani, N. D., Bloedon, L. T., Sterling, L. R., Robinson, P. L., & Ballantyne, C. M. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803917 · Cited by 807
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 795
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705
The interplay between cell signalling and the mevalonate pathway in cancer
Mullen, P. J., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.76 · Cited by 699
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
HIF1 and oxygen sensing in the brain
Sharp, F. R., & Bernaudin, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1408 · Cited by 568
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
DeWaal, D., Nogueira, V., Terry, A. R., Patra, K. C., Jeon, S.-M., Guzman, G., Au, J., Long, C. P., Antoniewicz, M. R., & Hay, N. (2018) · Nature Communications · doi:10.1038/s41467-017-02733-4 · Cited by 525
Qin, S., Bai, Y., Lim, H. Y., Thongprasert, S., Chao, Y., Fan, J., Yang, T.-S., Bhudhisawasdi, V., Kang, W. K., Zhou, Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5643 · Cited by 500
Schulte, M. L., Fu, A., Zhao, P., Li, J., Geng, L., Smith, S. T., Kondo, J., Coffey, R. J., Johnson, M. O., Rathmell, J. C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4464 · Cited by 494
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Nuciforo, S., Fofana, I., Matter, M. S., Blumer, T., Calabrese, D., Boldanova, T., Piscuoglio, S., Wieland, S., Ringnalda, F., Schwank, G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.001 · Cited by 473
Abou-Alfa, G. K., Johnson, P., Knox, J. J., Capanu, M., Davidenko, I., Lacava, J., Leung, T., Gansukh, B., & Saltz, L. B. (2010) · JAMA · doi:10.1001/jama.2010.1672 · Cited by 448
Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
Hitosugi, T., Zhou, L., Elf, S., Fan, J., Kang, H.-B., Seo, J. H., Shan, C., Dai, Q., Zhang, L., Xie, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.020 · Cited by 432
Zhao, Y., Li, M., Yao, X., Fei, Y., Lin, Z., Li, Z., Cai, K., Zhao, Y., & Luo, Z. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108487 · Cited by 412
Lally, J. S. V., Ghoshal, S., DePeralta, D. K., Moaven, O., Wei, L., Masia, R., Erstad, D. J., Fujiwara, N., Leong, V., Houde, V. P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.020 · Cited by 410
The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
Riganti, C., Gazzano, E., Polimeni, M., Aldieri, E., & Ghigo, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.006 · Cited by 408
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Guri, Y., Colombi, M., Dazert, E., Hindupur, S. K., Roszik, J., Moes, S., Jenoe, P., Heim, M. H., Riezman, I., Riezman, H., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.011 · Cited by 407
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Grohmann, M., Wiede, F., Dodd, G. T., Gurzov, E. N., Ooi, G. J., Butt, T., Rasmiena, A. A., Kaur, S., Gulati, T., Goh, P. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.053 · Cited by 373
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
Amann, T., Maegdefrau, U., Hartmann, A., Agaimy, A., Marienhagen, J., Weiss, T. S., Stoeltzing, O., Warnecke, C., Schölmerich, J., Oefner, P. J., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080596 · Cited by 368
Targeting the untargetable KRAS in cancer therapy
Liu, P., Wang, Y., & Li, X. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.03.002 · Cited by 366
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Xu, D., Wang, Z., Xia, Y., Shao, F., Xia, W., Wei, Y., Li, X., Qian, X., Lee, J.-H., Du, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2183-2 · Cited by 360
Structure of the human LAT1–4F2hc heteromeric amino acid transporter complex
Yan, R., Zhao, X., Lei, J., & Zhou, Q. (2019) · Nature · doi:10.1038/s41586-019-1011-z · Cited by 358
Huang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., Zhong, X., Jia, D., Song, L., Semenza, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.028 · Cited by 352
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Tong, X., Zhao, F., & Thompson, C. B. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.002 · Cited by 351
Nath, A., Li, I., Roberts, L. R., & Chan, C. (2015) · Scientific Reports · doi:10.1038/srep14752 · Cited by 338
Functional expression of sodium-glucose transporters in cancer
Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 329
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Bhutia, Y. D., & Ganapathy, V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.017 · Cited by 325
Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
Hardwick, J. P. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.004 · Cited by 322
Targeting Glutamine Metabolism for Cancer Treatment
Choi, Y.-K., & Park, K.-G. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.178 · Cited by 317
Unraveling the regulation of hepatic gluconeogenesis
Zhang, X., Yang, S., Chen, J., & Su, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00802 · Cited by 314
Self-citationSun, L., Song, L., Wan, Q., Wu, G., Li, X., Wang, Y., Wang, J., Liu, Z., Zhong, X., He, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.33 · Cited by 310
trans-2-Phenylcyclopropylamine Is a Mechanism-Based Inactivator of the Histone Demethylase LSD1
Schmidt, D. M. Z., & McCafferty, D. G. (2007) · Biochemistry · doi:10.1021/bi0618621 · Cited by 307
Falchook, G., Infante, J., Arkenau, H.-T., Patel, M. R., Dean, E., Borazanci, E., Brenner, A., Cook, N., Lopez, J., Pant, S., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100797 · Cited by 296
Novel roles for GAPDH in cell death and carcinogenesis
Colell, A., Green, D. R., & Ricci, J.-E. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.137 · Cited by 295
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Menendez, J. A., & Lupu, R. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1381087 · Cited by 293
Scalise, M., Galluccio, M., Console, L., Pochini, L., & Indiveri, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00243 · Cited by 281
Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
Montero, J., Morales, A., Llacuna, L., Lluis, J. M., Terrones, O., Basañez, G., Antonsson, B., Prieto, J., García-Ruiz, C., Colell, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6161 · Cited by 276
Recent insights into stearoyl-CoA desaturase-1
Ntambi, J. M., & Miyazaki, M. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200306000-00005 · Cited by 266
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
Scalise, M., Pochini, L., Console, L., Losso, M. A., & Indiveri, C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00096 · Cited by 265
Jiao, L., Zhang, H.-L., Li, D.-D., Yang, K.-L., Tang, J., Li, X., Ji, J., Yu, Y., Wu, R.-Y., Ravichandran, S., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1381804 · Cited by 264
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity
Thupari, J. N., Landree, L. E., Ronnett, G. V., & Kuhajda, F. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132128899 · Cited by 262
Langbein, S., Zerilli, M., zur Hausen, A., Staiger, W., Rensch-Boschert, K., Lukan, N., Popa, J., Ternullo, M. P., Steidler, A., Weiss, C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602962 · Cited by 261
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth
Montal, E. D., Dewi, R., Bhalla, K., Ou, L., Hwang, B. J., Ropell, A. E., Gordon, C., Liu, W.-J., DeBerardinis, R. J., Sudderth, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.025 · Cited by 259
Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
Febbraio, M. A., Reibe, S., Shalapour, S., Ooi, G. J., Watt, M. J., & Karin, M. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.012 · Cited by 253
Liu, X., Liang, Y., Song, R., Yang, G., Han, J., Lan, Y., Pan, S., Zhu, M., Liu, Y., Wang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0838-5 · Cited by 252
Transketolase counteracts oxidative stress to drive cancer development
Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., Law, C.-T., Wong, C.-M., Cai, Z., Wong, C. C.-L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508779113 · Cited by 251
Li, B., Cao, Y., Meng, G., Qian, L., Xu, T., Yan, C., Luo, O., Wang, S., Wei, J., Ding, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.063 · Cited by 245
ATP citrate lyase: A central metabolic enzyme in cancer
Icard, P., Wu, Z., Fournel, L., Coquerel, A., Lincet, H., & Alifano, M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.010 · Cited by 244
Metabolic rearrangements in primary liver cancers: cause and consequences
Satriano, L., Lewinska, M., Rodrigues, P. M., Banales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 243
Kaji, K., Nishimura, N., Seki, K., Sato, S., Saikawa, S., Nakanishi, K., Furukawa, M., Kawaratani, H., Kitade, M., Moriya, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31193 · Cited by 241
Seo, J., Jeong, D.-W., Park, J.-W., Lee, K.-W., Fukuda, J., & Chun, Y.-S. (2020) · Communications Biology · doi:10.1038/s42003-020-01367-5 · Cited by 237
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E., & Locasale, J. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.005 · Cited by 236
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229
Rimassa, L., Danesi, R., Pressiani, T., & Merle, P. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.05.004 · Cited by 228
The SLC transporter in nutrient and metabolic sensing, regulation, and drug development
Zhang, Y., Zhang, Y., Sun, K., Meng, Z., & Chen, L. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy052 · Cited by 226
Even Cancer Cells Watch Their Cholesterol!
Riscal, R., Skuli, N., & Simon, M. C. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.008 · Cited by 217
Liu, H., Liu, Y., & Zhang, J.-T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0445 · Cited by 216
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou, W., Simpson, P. J., McFadden, J. M., Townsend, C. A., Medghalchi, S. M., Vadlamudi, A., Pinn, M. L., Ronnett, G. V., & Kuhajda, F. P. (2003) · PubMed · Cited by 216
Liu, M.-X., Jin, L., Sun, S.-J., Liu, P., Feng, X., Cheng, Z.-L., Liu, W.-R., Guan, K.-L., Shi, Y.-H., Yuan, H.-X., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0070-6 · Cited by 212
Li, F., Huangyang, P., Burrows, M., Guo, K., Riscal, R., Godfrey, J., Lee, K. E., Lin, N., Lee, P., Blair, I. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0511-2 · Cited by 209
Type 2 diabetes as a redox disease
Watson, J. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62365-x · Cited by 206
Epigenetics in cancer therapy and nanomedicine
Roberti, A., Valdes, A. F., Torrecillas, R., Fraga, M. F., & Fernandez, A. F. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0675-4 · Cited by 205
Che, L., Chi, W., Qiao, Y., Zhang, J., Song, X., Liu, Y., Li, L., Jia, J., Pilo, M. G., Wang, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317581 · Cited by 203
Shukla, K., Ferraris, D. V., Thomas, A. G., Stathis, M., Duvall, B., Delahanty, G., Alt, J., Rais, R., Rojas, C., Gao, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301191p · Cited by 199
Liberti, M. V., Dai, Z., Wardell, S. E., Baccile, J. A., Liu, X., Gao, X., Baldi, R., Mehrmohamadi, M., Johnson, M. O., Madhukar, N. S., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.017 · Cited by 199
Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target
Buckley, D., Duke, G., Heuer, T. S., O'Farrell, M., Wagman, A. S., McCulloch, W., & Kemble, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.021 · Cited by 196
Lipolysis and lipases in white adipose tissue – An update
Bolsoni-Lopes, A., & Alonso-Vale, M. I. C. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000067 · Cited by 183
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
Zhai, B. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i7.345 · Cited by 183
Menendez, J. A., Vellon, L., & Lupu, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi239 · Cited by 179
Okano, N., Naruge, D., Kawai, K., Kobayashi, T., Nagashima, F., Endou, H., & Furuse, J. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00924-3 · Cited by 178
Jin, H., Wang, S., Zaal, E. A., Wang, C., Wu, H., Bosma, A., Jochems, F., Isima, N., Jin, G., Lieftink, C., et al. (2020) · eLife · doi:10.7554/elife.56749 · Cited by 178
Ma, M. K. F., Lau, E. Y. T., Leung, D. H. W., Lo, J., Ho, N. P. Y., Cheng, L. K. W., Ma, S., Lin, C. H., Copland, J. A., Ding, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.015 · Cited by 177
Shiba, K., Tsuchiya, K., Komiya, C., Miyachi, Y., Mori, K., Shimazu, N., Yamaguchi, S., Ogasawara, N., Katoh, M., Itoh, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19658-7 · Cited by 175
Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
Pereira Da Silva, A. P., El-Bacha, T., Kyaw, N., Dos Santos, R. S., Da-Silva, W. S., Almeida, F. C. L., Da Poian, A. T., & Galina, A. (2009) · Biochemical Journal · doi:10.1042/bj20080805 · Cited by 170
Gutierrez, M. J., Rosenberg, N. L., MacDougall, D. E., Hanselman, J. C., Margulies, J. R., Strange, P., Milad, M. A., McBride, S. J., & Newton, R. S. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302677 · Cited by 170
Xu, D., Jin, J., Yu, H., Zhao, Z., Ma, D., Zhang, C., & Jiang, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0514-4 · Cited by 169
Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
Li, S., Li, J., Dai, W., Zhang, Q., Feng, J., Wu, L., Liu, T., Yu, Q., Xu, S., Wang, W., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.323 · Cited by 166
Lai, K. K. Y., Kweon, S.-M., Chi, F., Hwang, E., Kabe, Y., Higashiyama, R., Qin, L., Yan, R., Wu, R. P., Lai, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.021 · Cited by 165
The Lipogenesis Pathway as a Cancer Target
Abramson, H. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2005805 · Cited by 165
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
Ma, R., Zhang, W., Tang, K., Zhang, H., Zhang, Y., Li, D., Li, Y., Xu, P., Luo, S., Cai, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3508 · Cited by 163
Ivosidenib: First Global Approval
Dhillon, S. (2018) · Drugs · doi:10.1007/s40265-018-0978-3 · Cited by 162
Caravella, J. A., Lin, J., Diebold, R. B., Campbell, A.-M., Ericsson, A. M., Gustafson, G. R., Wang, Z., Castro, J., Clarke, A., Gotur, D., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01423 · Cited by 161
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
Kanwal, F., Kramer, J. R., Duan, Z., Yu, X., White, D., & El-Serag, H. B. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.010 · Cited by 159
Park, Y., Sohn, B. H., Johnson, R. L., Kang, M., Kim, S. B., Shim, J., Mangala, L. S., Kim, J. H., Yoo, J. E., Rodriguez‐Aguayo, C., et al. (2015) · Hepatology · doi:10.1002/hep.28223 · Cited by 159
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Degasperi, E., & Colombo, M. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30018-8 · Cited by 157
Wang, M., Wu, H., Fu, G., Zhang, H., Zhou, X., Tang, L., Dong, L., Qin, C., Huang, S., Zhao, L., et al. (2015) · Hepatology · doi:10.1002/hep.28415 · Cited by 152
Gao, Y., Islam, M. S., Tian, J., Lui, V. W. Y., & Xiao, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.015 · Cited by 150
Li, C., Yang, W., Zhang, J., Zheng, X. M., Yao, Y., Tu, K., & Liu, Q. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057124 · Cited by 138
Lü, M., Lu, L., Dong, Q., Yu, G., Chen, J., Qin, L., Wang, L.-X., Zhu, W., & Jia, H. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy009 · Cited by 138
PGK1-mediated cancer progression and drug resistance.
He, Y., Yang, L., Zhang, D., Wang, X., Zhang, P., Li, H., Ejaz, S., & Liang, S. (2019) · PubMed · Cited by 136
Xu, J., Ji, L., Ruan, Y., Wan, Z., Lin, Z., Xia, S., Tao, L., Zheng, J., Cai, L., Wang, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00594-4 · Cited by 135
Wu, H., Pan, L., Gao, C., Xu, H., Li, Y., Zhang, L., Ma, L., Li, M., Sun, X., & Qin, H. (2019) · Molecules · doi:10.3390/molecules24101993 · Cited by 134
Jin, X., Pan, Y., Wang, L., Zhang, L., Ravichandran, R., Potts, P. R., Jiang, J., Wu, H., & Huang, H. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.21 · Cited by 131
Ahn, S. B., Jang, K., Jun, D. W., Lee, B. H., & Shin, K. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3289-x · Cited by 128
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
Chen, K., Qian, W., Jiang, Z., Cheng, L., Li, J., Sun, L., Zhou, C., Gao, L., Lei, M., Yan, B., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0701-0 · Cited by 126
Liu, G., Kuang, S., Cao, R., Wang, J., Peng, Q., & Sun, C. (2019) · The FASEB Journal · doi:10.1096/fj.201802619rr · Cited by 126
Zaytseva, Y. Y., Rychahou, P. G., Le, A.-T., Scott, T. L., Flight, R. M., Kim, J. T., Harris, J., Liu, J., Wang, C., Morris, A. J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25361 · Cited by 123
Hong, X.-H., Song, R.-P., Song, H.-W., Zheng, T., Wang, J.-B., Liang, Y.-J., Qi, S., Lu, Z., Song, X., Jiang, H.-C., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305302 · Cited by 123
GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
Sun, H.-W., Yu, X.-J., Wu, W., Chen, J., Shi, M., Zheng, L., & Xu, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168907 · Cited by 123
Ganapathy‐Kanniappan, S., Geschwind, J.-F. H., Kunjithapatham, R., Buijs, M., Vossen, J. A., Tchernyshyov, I., Cole, R. N., Syed, L. H., Rao, P. P., Ota, S., et al. (2009) · PubMed · Cited by 121
Rieger, M. A., Ebner, R., Bell, D., Kießling, A., Rohayem, J., Schmitz, M., Temme, A., Rieber, E. P., & Weigle, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0849 · Cited by 117
Huang, G.-M., Jiang, Q., Cai, C., Qu, M., & Shen, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.036 · Cited by 109
Graf, H., Jüngst, C., Straub, G., Dogan, S., Hoffmann, R., Jakobs, T. F., Reiser, M. F., Waggershauser, T., Helmberger, T. K., Walter, A., et al. (2008) · Digestion · doi:10.1159/000156702 · Cited by 108
Dysregulated Fatty Acid Metabolism in Hepatocellular Carcinoma
Wang, M.-D., Han, J. S., Xing, H., Zhang, H., Li, Z., Liang, L., Li, C., Dai, S., Wu, M., Shen, F., et al. (2016) · Hepatic Oncology · doi:10.2217/hep-2016-0012 · Cited by 108
Liu, W.-R., Tian, M., Yang, L., Lin, Y., Jin, L., Ding, Z., Shen, Y., Peng, Y., Gao, D., Zhou, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2749 · Cited by 107
Chen, J., Ding, C., Chen, Y., Hu, W., Lu, Y., Wu, W., Zhang, Y., Yang, B., Wu, H., Peng, C., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0226-z · Cited by 107
Intestinal SGLT1 in metabolic health and disease
Lehmann, A., & Hornby, P. J. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00068.2016 · Cited by 104
Yang, H. J., Jin, X., Yan, Y., Shao, Y., Pan, Y., Roberts, L. R., Zhang, J., Huang, H., & Jiang, J. (2017) · Scientific Reports · doi:10.1038/srep43864 · Cited by 103
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
Du, K., Chitneni, S. K., Suzuki, A., Wang, Y., Henao, R., Hyun, J., Premont, R. T., Naggie, S., Moylan, C. A., Bashir, M. R., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.12.006 · Cited by 103
Qin, Z., Xiang, C., Zhong, F., Liu, Y., Dong, Q., Li, K., Shi, W., Ding, C., Qin, L., & He, F. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1131-1 · Cited by 101
Liu, S., Sun, Y., Jiang, M., Li, Y., Tian, Y., Xue, W., Ding, N., Sun, Y., Cheng, C., Li, J., et al. (2017) · Hepatology · doi:10.1002/hep.29202 · Cited by 100
Mossenta, M., Busato, D., Bo, M. D., & Toffoli, G. (2020) · Cancers · doi:10.3390/cancers12061668 · Cited by 98
Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer
Attané, C., & Muller, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.03.001 · Cited by 97
Kim, H.-J., Hwang, K., Park, D., Oh, S., Jun, H. Y., Yoon, K., Jeong, E., Kim, Y. S., & Kim, Y. S. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1223-7 · Cited by 97
Hu, L., Zeng, Z., Xia, Q., Liu, Z., Feng, X., Chen, J., Huang, M., Chen, L., Fang, Z., Liu, Q., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116966 · Cited by 96
Jarrar, Y. B., & Lee, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174274 · Cited by 94
Chen, Z., Li, D., Xu, N., Fang, J., Yu, Y., Hou, W., Ruan, H., Zhu, P., Ma, R., Lu, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01198 · Cited by 91
Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer
Yu, W., Chai, H., Li, Y., Zhao, H., Xie, X., Zheng, H., Wang, C., Wang, X., Yang, G., Cai, X., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.019 · Cited by 86
Sukhatme, V. P., & Chan, B. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.052 · Cited by 83
Wang, L., Yang, Q., Peng, S., & Liu, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s212465 · Cited by 83
Bai, M., Yang, L., Liao, H., Liang, X., Xie, B., Xiong, J., Tao, X., Chen, X., Cheng, Y., Chen, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0360-7 · Cited by 81
Self-citationOhkame, H., Masuda, H., Ishii, Y., & Kanai, Y. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1165 · Cited by 80
The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma
You, J., Chen, W., Chen, J., Zheng, Q., Dong, J., & Zhu, Y. (2018) · BioMed Research International · doi:10.1155/2018/2109865 · Cited by 80
Ohata, T., Yokoo, H., Kamiyama, T., Fukai, M., Aiyama, T., Hatanaka, Y., Hatanaka, K. C., Wakayama, K., Orimo, T., Kakisaka, T., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1020 · Cited by 78
Che, L., Paliogiannis, P., Cigliano, A., Pilo, M. G., Chen, X., & Calvisi, D. F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01412 · Cited by 78
Wen, D., Liu, D., Tang, J., Dong, L., Liu, Y., Tao, Z., Wan, J.-L., Gao, D., Wang, L., Sun, H., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3306-5 · Cited by 77
Kawai, K., Uemura, M., Munakata, K., Takahashi, H., Haraguchi, N., Nishimura, J., Hata, T., Matsuda, C., Ikenaga, M., Murata, K., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3814 · Cited by 77
Bhushan, B., Banerjee, S., Paranjpe, S., Koral, K., Mars, W. M., Stoops, J. W., Orr, A. V., Bowen, W. C., Locker, J. D., & Michalopoulos, G. K. (2019) · Hepatology · doi:10.1002/hep.30696 · Cited by 77
Cho, J., Kim, G.-Y., Pan, C., Anduaga, J., Choi, E., Mansfield, B. C., & CHOU, J. Y. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006819 · Cited by 76
Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers
Gingold, J. A., Zhu, D., Lee, D., Kaseb, A. O., & Chen, J. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.006 · Cited by 75
NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis
Guo, H., Xu, J., Zheng, Q., He, J., Zhou, W., Wang, K., Huang, X., Fan, Q., Ma, J., Cheng, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.010 · Cited by 74
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma
Kim, G. P., Mahoney, M. R., Szydlo, D. W., Mok, T. S. K., Marschke, R. F., Holen, K. D., Picus, J., Boyer, M. J., Pitot, H. C., Rubin, J., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9532-1 · Cited by 72
Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
Zhang, P., Wang, Q., Lin, Z., Yang, P., Dou, K., & Zhang, R. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s235667 · Cited by 70
Tang, J., Ren, Y., Zhao, J., Long, F., Chen, J.-Y., & Jiang, Z. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.012 · Cited by 69
GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway
Xi, J., Sun, Y., Zhang, M., Fa, Z., Wan, Y.-Y., Min, Z., Xu, H., Xu, C., & Tang, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.005 · Cited by 69
Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency
Martínez, A. I., Pérez-Arellano, I., Pekkala, S., Barcelona, B., & Cervera, J. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.08.002 · Cited by 67
Chung-Yu, K., Liu, Y.-H., Lin, H.-Y., Lu, S., & Lin, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7571 · Cited by 64
Obara, K., Shirakami, Y., Maruta, A., Ideta, T., Miyazaki, T., Kochi, T., Sakai, H., Tanaka, T., Seishima, M., & Shimizu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.16874 · Cited by 63
Metformin in breast cancer - an evolving mystery
Camacho, L., Dasgupta, A., & Jiralerspong, S. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0598-8 · Cited by 62
Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
Wu, Z.-C., Ma, H., Wang, L.-Y., Song, X.-J., Zhang, J., Liu, W., Ge, Y.-T., Sun, Y., Yu, X., Wang, Z.-H., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0453-z · Cited by 59
Jeong, C., Hah, Y., Cho, B.-I., Lee, S. M., Joo, Y.-T., Jung, E., Jeong, S., Lee, Y., Choi, S.-K., Ha, W., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1922 · Cited by 58
Zhu, W., Zhao, Y., Zhou, J., Wang, X., Pan, Q., Zhang, N., Wang, L., Wang, M., Zhan, D.-H., Liu, Z., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0361-3 · Cited by 58
Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation
Pan, D., Mao, C., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066294 · Cited by 57
Sun, J., Li, J., Guo, Z., Sun, L., Juan, C., Zhou, Y., Gu, H., Yu, Y. H., Hu, Q., Kan, Q., et al. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15180451872087 · Cited by 57
Wei, X., Mao, T., Li, S., He, J., Hou, X., Li, H., Zhan, M., Yang, X., Li, R., Xiao, J., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.003 · Cited by 55
Self-citationPCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway
Tuo, L., Jin, X., Pan, X., Gao, Q., Zhang, G., Yang, Y., Liang, L., Xia, J. L., Wang, K., & Tang, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00611 · Cited by 55
Guzman, G., Chennuri, R., Chan, A., Rea, B. A., Quintana, A., Patel, R., Xu, P.-Z., Xie, H. W., & Hay, N. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3364-3 · Cited by 54
Bungard, C., & McGivan, J. (2004) · Biochemical Journal · doi:10.1042/bj20040487 · Cited by 53
Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration
Janpipatkul, K., Suksen, K., Borwornpinyo, S., Jearawiriyapaisarn, N., Hongeng, S., Piyachaturawat, P., & Chairoungdua, A. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.002 · Cited by 52
Pantziarka, P., Pirmohamed, M., & Mirza, N. (2018) · BMJ · doi:10.1136/bmj.k2701 · Cited by 52
Xiong, T., Li, Z., Huang, X., Lu, K., Xie, W., Zhou, Z., & Tu, J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00061.2018 · Cited by 51
Li, M., Shao, J., Guo, Z., Jin, C., Wang, L., Wang, F., Jia, Y., Zhu, Z., Zhang, Z., Zhang, F., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14971 · Cited by 51
Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
Wang, W., Jiang, Z., Hu, C., Chen, C., Hu, Z., Wang, A., Wang, L., Liu, J. L., Wang, W., & Liu, Q. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0465-8 · Cited by 51
Silvestri, A., Palumbo, F., Rasi, I., Posca, D., Pavlidou, T., Paoluzi, S., Castagnoli, L., & Cesareni, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136250 · Cited by 50
Sun, X., Sun, G., Huang, Y., Hao, Y., Tang, X., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113988 · Cited by 49
Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer
Wang, L., Liu, Y., Zhao, T., Li, Z., He, J., Zhang, B.-J., Du, H., Jiang, J., Yuan, S., & Sun, L. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.011 · Cited by 47
Self-citationTao, X., Zuo, Q., Ruan, H., Wang, H., Jin, H., Cheng, Z., Lv, Y., Qin, W., & Wang, C. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz005 · Cited by 47
Xiong, J., Liu, T., Mi, L., Kuang, H., Xiong, X., Chen, Z., Li, S., & Lin, J. D. (2019) · Hepatology · doi:10.1002/hep.30921 · Cited by 47
Self-citationAnti-Cancer Effects of Emodin on HepG2 Cells as Revealed by 1H NMR Based Metabolic Profiling
Xing, Y.-X., Li, M.-H., Tao, L., Ruan, L.-Y., Hong, W., Chen, C., Zhao, W.-L., Xu, H., Chen, J.-F., & Wang, J.-S. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00029 · Cited by 46
Lu, X., Zhang, X.-H., Zhang, Y., Zhang, K., Zhan, C., Shi, X., Li, Y., Zhao, J.-X., Bai, Y.-F., Wang, Y., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22967 · Cited by 45
Self-citationPKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells
Dey, P. K., Kundu, A. B., Sachan, R., Park, J. H., Ahn, M. Y., Yoon, K., Lee, J., Kim, N. D., Kim, I. S., Lee, B. M., et al. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000107 · Cited by 45
Kim, D., Brocker, C. N., Takahashi, S., Yagai, T., Kim, T., Xie, G., Wang, H., Qu, A., & Gonzalez, F. J. (2019) · Hepatology · doi:10.1002/hep.30530 · Cited by 45
Lee, M., Ko, H. Y., & Yun, M. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.10.1143 · Cited by 43
Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis
Shao, C., Lu, W., Du, Y., Yan, W., Bao, Q., Tian, Y., Wang, G., Ye, H., & Hao, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101685 · Cited by 43
Self-citationChen, Z., Zhuang, W., Wang, Z., Xiao, W., Don, W., Li, X., & Chen, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29196 · Cited by 42
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2016) · Oncology Letters · doi:10.3892/ol.2016.5510 · Cited by 39
Cited by
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
Fontana, F., Giannitti, G., Marchesi, S., & Limonta, P. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89942 · Cited by 280
Gajos-Michniewicz, A., & Czyz, M. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.050 · Cited by 89
Fu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07005-0 · Cited by 13
Self-citationCitalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1+ TAMs
Dong, F., Zhang, S., Song, K., Jiang, L., Hu, L.-P., Li, Q., Zhang, X.-L., Li, J., Feng, M., Cai, Z.-W., et al. (2026) · eLife · doi:10.7554/elife.103016 · Cited by 2
Self-citation
Metadata
- Authors
- Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 12
- Issue
- 2
- Pages
- 558-580
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3204325474
- Cited by
- 643
- References
- 217
- FWCI
- 26.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.